Cherwell Opens Expanded Redipor Prepared Media Manufacturing Facility
Cherwell Laboratories, manufacturer of Redipor prepared microbiological media, has completed an expansion programme at its Bicester-based facility. Initiated in response to a significant increase in demand, Cherwell has doubled the size of its cleanroom manufacturing suite and recruited additional staff to support the higher production capacity. Cherwell is renowned for offering a flexible supply of quality prepared media products, and the expanded facility ensures increasing demand in the UK and mainland Europe can be accommodated.
Cherwell’s continuing growth is partly fuelled by the development of export sales — up 55% in the past 2 years — and the appointment of further European distributors for the Redipor range. Already supported in Italy, Ireland, Poland and Slovenia, Cherwell has recently signed distributor agreements with AcefeSA in Spain and Dorte Egelund in Denmark. The company has carefully selected partners with the capability to deliver the same quality of service enjoyed by its UK customers.
The company has increased its UK market share through a dedication to customer service and the ability to deliver bespoke prepared media solutions. Many customers are switching to the convenience of Redipor pre-prepared media rather than making their own onsite. Increased pressure by regulators for more environmental monitoring has also led to overall growth in the prepared media market. Notably, demand for Redipor Barrier pack products, for use in isolators where vaporised hydrogen peroxide (VHP) is present, has grown, reflecting the increased use of VHP technology for sterilisation procedures.
Andy Whittard, Managing Director, Cherwell Laboratories commented: “This investment in facilities and capabilities is a clear indication of our commitment to developing our position as a leading supplier of prepared media. Recent market research shows our customers value not just the quality of our products, but increasingly our service and support. Most importantly, we are consistently delivering what our customers want.”
He added: “By developing our export markets through carefully selected partners, we aim to continue growing our UK-based production in a controlled manner, keeping excellent service and the customer at the core of what we do.”
Related News
-
News WuXi to sell CGT manufacturing unit to US-based Altaris LLC
At the tail end of 2024, Chinese-based CDMO WuXi AppTec announced the signing of their deal with private equity firm Altaris LLC, confirming the sale of WuXi Advanced Therapies, the cell and gene therapy manufacturing arm of WuXi AppTec. -
News Women in Pharma: Our hopes for 2025 and beyond
Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the... -
News CPHI Milan Wrap-Up Report: Conference Highlights
Discover the emerging and trending topics of the pharmaceutical industry with our CPHI Milan Conference Highlights, with exclusive insight from pharmaceutical leaders and experts! -
News BIOSECURE Act not included in key defense spending bill for 2025
On December 7, 2024, the Biden administration revealed the 2025 National Defense Authorization Act, an annual defense bill specifying the budget and expenditures of the US Department of Defense. The controversial BIOSECURE Act was notably missing from ... -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News Trump 2.0: What does the US election result mean for the healthcare industry?
After Trump won the Presidential election in the US in early November, we take a look at some of the implications a new Trump administration could have on the health and pharmaceutical industry, and on US patients. -
News Women in Pharma: Reflections from Behind the Scenes
In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future. -
News Scaling the Industry: CPHI Scale-Up Market interview with YSK Laboratories
For the first time, CPHI Milan hosted the CPHI Start-Up Market, expanding support for emerging and small-sized enterprises in their transition to the next level of growth. In this interview, we spoke with Yuvansh Khokhani, Managing Director of YSK Labo...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance